Teligent (NASDAQ:TLGT) is scheduled to be issuing its quarterly earnings data after the market closes on Monday, August 5th. Analysts expect the company to announce earnings of ($0.04) per share for the quarter.
Teligent (NASDAQ:TLGT) last posted its quarterly earnings results on Monday, May 6th. The company reported ($0.10) EPS for the quarter, missing the consensus estimate of ($0.08) by ($0.02). Teligent had a negative net margin of 73.56% and a negative return on equity of 103.41%. The business had revenue of $13.12 million during the quarter, compared to the consensus estimate of $16.60 million. On average, analysts expect Teligent to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
NASDAQ:TLGT opened at $0.68 on Friday. The company has a debt-to-equity ratio of 14.43, a quick ratio of 0.79 and a current ratio of 1.46. The company has a market cap of $35.00 million, a price-to-earnings ratio of -2.06 and a beta of 1.59. The firm has a 50-day simple moving average of $0.65. Teligent has a one year low of $0.42 and a one year high of $4.52.
Separately, ValuEngine lowered shares of Teligent from a “buy” rating to a “hold” rating in a research note on Thursday, May 23rd.
Teligent, Inc, a specialty generic pharmaceutical company, develops, manufactures, markets, and sells generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. It offers generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms.
Read More: Trading Ex-Dividend
Receive News & Ratings for Teligent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teligent and related companies with MarketBeat.com's FREE daily email newsletter.